Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial
Edward M. Kerwin, Isabelle H. Boucot, Claus F. Vogelmeier, Francois Maltais, Ian P. Naya, Lee Tombs, Paul W. Jones, David A. Lipson, Tom Keeley, Leif Bjermer
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial'. Together they form a unique fingerprint.